M. Schumacher

H. Voss1
D. E. Plane1
A. Essig1
S. Braibant1
1H. Voss
1D. E. Plane
1A. Essig
1S. Braibant
Learn More
Classical end-points in clinical therapeutic trials in oncology are usually defined by total, recurrence-free or systemic disease-free survival. Primarily, these allow an adequate description of the biological course of the disease. In current oncological research advances in the treatment of cancer patients as measured by these end-points must(More)
We analyzed individual-level data on pandemic influenza A/H1N1pdm hospitalizations from the enhanced surveillance system of the Maricopa County Department of Public Health, AZ, USA from April 1st, 2009 to March 31st, 2010. We also assessed the the risk of death among A/H1N1 hospitalizations using multivariate logistic regression. Hospitalization rates were(More)
  • G. Abbiendi, C. Ainsley, P. F. Åkesson, G. Alexander, G. Anagnostou, K. J. Anderson +206 others
  • 2012
A search is made for charged Higgs bosons predicted by Two-Higgs-Doublet extensions of the Standard Model (2HDM) using electron-positron collision data collected by the OPAL experiment at √ s = 189–209 GeV, corresponding to an integrated luminosity of approximately 600 pb −1. Charged Higgs bosons are assumed to be pair-produced and to decay into q¯ q, τ ν τ(More)
Symptoms of acute febrile respiratory tract infection are often unspecific, but the rapid identification of pathogens allows optimised patient management. The objective of this study was to evaluate a novel multiplex polymerase chain reaction (PCR) suspension microarray which detects 19 viral and four atypical bacterial targets. A comprehensive set of(More)
  • 1